5-(2,2-difluorobenzo(1,3)dioxol-5-ylmethylene)thiazolidine-2,4-dione,
AS 604850,
AS-604850,
AS604850,
AS-604850,
AS 604850,
PI 3-Kgamma Inhibitor II,
648449-76-7,
(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE,
PI3Kgamma inhibitor,
(5Z)-5-[(2,2-difluoro-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione,
BYM,
5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione,
AC1NRAFN,
2a4z,
AS604850,
PI 3-Kg inhibitor II,
MLS006010996,
GTPL6024,
SCHEMBL1804516,
CHEMBL1231533,
CHEBI:94690,
BCPP000389,
HMS3229I21,
HMS3261F11,
HMS3650F11,
Tox21_500505,
s2681,
ZINC33821235,
BCP9000322,
CCG-206780,
DB07503,
LP00505,
NCGC00186009-01,
NCGC00186009-04,
NCGC00261190-01,
SMR001456260,
RT-011325,
SW219919-1,
AS 604850, >=98% (HPLC), solid,
SR-02000000900,
SR-02000000900-2,
BRD-K63915849-001-01-1,
AS604850;AS-604850;648449-76-7,
(5Z)-5-[(2,2-difluoro-2H-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione,
D03DRM,
cc-611,
CID5287855,
B2181,
C505145,
5-(2,2-difluorobenzo(1,3)dioxol-5-ylmethylene)thiazolidine-2,4-dione,